NY Gov. Andrew Cuomo Supports Truvada for PrEP | Pharmaguy's Insights Into Drug Industry News | Scoop.it

New York's governor is backing a new and controversial strategy for reducing the number of new infections in the state.

He has embraced a new and controversial treatment for people at risk of contracting H.I.V. He wants to put more H.I.V.-negative people on Truvada, a drug originally developed to treat those who already have the virus, and which the F.D.A. approved in 2012 as protection against new infections.

This strategy, known as pre-exposure prophylaxis (PrEP), is one of three planks in Governor Cuomo’s broad plan to cut H.I.V. infections, and the most novel one. The other two (testing more people and getting those who test positive to see doctors; getting H.I.V.-positive people to stay in treatment and on medication) are strategies that New York and other states have pursued for decades with varying degrees of success.